Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02179, also known as Long intergenic non-protein coding RNA 2179 and by aliases such as RP11-189E14.4, is a long non-coding RNA transcript gene located in the human genome. LincRNAs like LINC02179 are defined by their absence of protein-coding potential and their positioning in intergenic regions—distinct from other long non-coding RNAs that may overlap coding loci. Generally, lincRNAs participate in fine-tuning gene expression, chromatin architecture, transcriptional regulation, and RNA stabilization, and may show tissue specificity in their activities[3]. While thousands of lincRNAs have been discovered, only a minority have been directly linked to defined molecular or disease roles, and for LINC02179 specifically, there is no detailed functional, disease, or pharmacological annotation[1][3]. As such, LINC02179 should be considered a non-protein coding RNA lacking current evidence as a drug target or clinical biomarker.
None known; no drugs reported or predicted to act directly on LINC02179[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2179 (LINC02179).